What are the treatment options for psoriasis (psoriasis) of the scalp?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Scalp Psoriasis

Topical corticosteroids are the first-line treatment for scalp psoriasis, with specialized formulations like solutions, foams, and shampoos providing the most effective and patient-friendly delivery methods. 1

First-Line Treatment: Topical Corticosteroids

  • Topical corticosteroids are recommended as initial therapy for scalp psoriasis with efficacy rates ranging from 41% to 92% depending on potency class 1
  • For mild to moderate scalp psoriasis, use class 3-7 corticosteroids; for moderate to severe cases, use class 1-2 (high-potency) corticosteroids 1
  • Treatment duration should be up to 4 weeks initially, with longer use (>12 weeks) requiring careful physician supervision 1
  • Vehicle formulations specifically designed for scalp application (solutions, foams, shampoos) improve adherence and efficacy compared to creams or ointments which can be messy in hair-bearing areas 2
  • Clobetasol propionate solution is highly effective but may cause local adverse effects including burning/stinging sensation (reported in 29 of 294 patients), scalp pustules, and folliculitis 3

Vitamin D Analogues

  • Calcipotriene (calcipotriol) foam is effective for scalp psoriasis, with 40.9% of patients achieving clear or almost clear status after 8 weeks compared to 24.2% with vehicle 2
  • Vitamin D analogues show efficacy at 8 weeks but not at 4 weeks, which should be considered when planning treatment duration 2
  • Calcipotriene foam and calcipotriene plus betamethasone dipropionate gel for 4-12 weeks are safe and effective for mild to moderate scalp psoriasis 2
  • UVA radiation can decrease the concentration of calcipotriene on the skin, so it should be applied after phototherapy to avoid inactivation 2

Combination Therapy

  • Combination of calcipotriene with potent corticosteroids is more effective than either agent alone for treating psoriasis 2
  • A 52-week study showed 69-74% of patients treated with calcipotriene 0.005% plus betamethasone 0.064% once or twice daily achieved clear or almost clear status compared with 27% with vehicle control 2
  • No serious adverse events, including striae or hypothalamic-pituitary-adrenal axis suppression, were observed over the 52-week treatment period with this combination 2
  • For long-term management, gradually reduce frequency of corticosteroid application and consider combination with vitamin D3 derivatives or coal tar-containing shampoo 1, 4

Treatment Algorithm

  1. Initial Assessment: Evaluate severity of scalp psoriasis (mild, moderate, severe) 2
  2. First-line therapy:
    • For mild-moderate: Class 3-7 topical corticosteroid in a solution, foam, or shampoo formulation 1
    • For moderate-severe: Class 1-2 topical corticosteroid (like clobetasol propionate solution) 1, 3
  3. Treatment duration: Use daily for up to 4 weeks 1
  4. Maintenance therapy:
    • Gradually reduce frequency to prevent rebound 1
    • Consider alternating with vitamin D analogues 2, 4
  5. For resistant cases:
    • Combination therapy with calcipotriene plus betamethasone 2
    • Consider intralesional corticosteroids for localized thick lesions 1
    • For severe recalcitrant cases, systemic therapies may be required 5, 6

Important Considerations and Pitfalls

  • Scalp psoriasis is notoriously difficult to treat due to the presence of hair making application challenging 2
  • Poor adherence to treatment regimens is common (up to 40% of patients), often due to inconvenience, time constraints, and frustration with messy formulations 2
  • Hypothalamic-pituitary-adrenal (HPA) axis suppression is possible with prolonged use of potent topical corticosteroids but is typically transient and reversible upon completion of a 2-week course of treatment 3
  • Local adverse effects of topical corticosteroids include burning, stinging, folliculitis, skin atrophy, and telangiectasia 3
  • For women of childbearing potential, most topical psoriasis medications are pregnancy category C, and tazarotene is category X 2

References

Guideline

Treatment of Scalp Psoriasis with Topical Corticosteroids

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of scalp psoriasis: current perspectives.

Psoriasis (Auckland, N.Z.), 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.